ABCL
AbCellera BiologicsFNasdaq / Pharmaceuticals, Biotechnology & Life Sciences
Last Price
Quote time unavailable
+
Peers tracked
10
U.S. public peers
Grade Position
Below peers
vs peer average
ABCL vs peer average
24/100
ABCL vs. peer average (F vs. C)
Grade spread
B 2 · C 3 · D 4 · F 1
Graded peers loaded
Coverage
10 graded
100% of tracked
Peer overview
IMCR is the first available peer comparator.
Immunocore is a closer clinical-stage biotech comp where valuation is still heavily milestone-driven, although modality and commercial maturity differ, so read-through for ABCL remains limited.
✓Peer source comes from the stored AI memo or peer model
✓Grades and factor rows use RankAlpha API data when available
✓Missing peer scores remain blank instead of being estimated
✓Side-by-side comparison keeps the data contract visible
ABCL
AbCellera Biologics
IMCR
Immunocore American
Grade
F
D
Momentum
99
56
Value
41
41
Sentiment
0
-
Setup Bias
Net —
-
Market Cap
-
-
Posture
Defensive
Defensive
Grade position vs IMCR
ABCL / IMCR
Grade Position
Below peers
ABCL vs. peer average (F vs. C)
24/100
Momentum
99
ABCLValue
41
ABCLSentiment
0
-Rotation landscape
Peers ranked by the order returned from the peer source, with grades from the API.
Rank
Ticker
Company
Grade
Grade score
vs ABCL
IMCR is the first peer returned for this comparison set.

